Bio Pharma
The science, scale-up and economics reshaping biologics and advanced therapies.
BiologicsCell & geneCMCScale-up
ArticleLead story
Pharma Patent Cliff 2028: Who Is Exposed and How They Respond
Pharma Patent Cliff 2028: Keytruda and Eliquis lead $99 billion of exposed sales. See who is at risk, how fast sales fall, and how drugmakers respond.
Vaibhavi M. · Oct 26, 2026
Article
Every Company Announced Fill-Finish Capacity: Still Scarce?
Everyone announced more fill-finish capacity, so why is it still one of biopharma's tightest bottlenecks? Here's the gap between announcement and reality.
Simantini Singh Deo · Aug 28, 2026
Article
Why Oral GLP-1 Manufacturing Capacity Decides The Leader
Behind every oral GLP-1 approval is a manufacturing story, here's why factory capacity, not trial data, could decide who leads this market.
Simantini Singh Deo · Aug 26, 2026
Key voices
